• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AUGMENIX, INC. SPACEOAR; HYDROGEL SPACER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AUGMENIX, INC. SPACEOAR; HYDROGEL SPACER Back to Search Results
Catalog Number SO-2101
Device Problem Insufficient Information (3190)
Patient Problem Sudden Cardiac Death (2510)
Event Date 02/11/2019
Event Type  Injury  
Manufacturer Narrative
On (b)(6) 2019, the patient underwent a procedure to implant spaceoar and ldr brachytherapy seeds.The patient was provided with 0.5mg ativan prior to the procedure and the procedure was performed under local anesthesia.During the procedure, visibility was limited so the implanting physician performed an enema to void the bowel of stool.The procedure appeared to go smoothly.The implanting physician aspirated to check for vascular involvement during the procedure and no blood was detected.Following the procedure, the patient complained of dizziness and nausea.The patient's energy began to diminish, and speech became incoherent.The patient then lost consciousness.Resuscitation efforts began, and the patient was transported to the hospital.The patient's wife informed the implanting physician that the patient was feeling nauseous and unwell prior to the procedure.The patient was placed on a ventilator upon arrival at the hospital.Echocardiogram showed evidence of pericardial effusion, but it is currently unknown if this was a result of chest compressions or an underlying condition.On (b)(6) 2019, the patient was disconnected from the ventilator and passed away.At this time, a death certificate and official cause of death is not available.The patient did not receive any post procedure imaging of the pelvic area.From the available information, the cause of the patient's death cannot be conclusively determined.
 
Event Description
It was reported that following a procedure to implant spaceoar and ldr seeds, the patient complained of dizziness and nausea.The patient subsequently lost consciousness and resuscitation efforts began.The patient was transported to the hospital where he later passed away.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPACEOAR
Type of Device
HYDROGEL SPACER
Manufacturer (Section D)
AUGMENIX, INC.
201 burlington rd.
bedford MA 01730
Manufacturer (Section G)
AUGMENIX, INC.
201 burlington rd.
bedford MA 01730
Manufacturer Contact
james mayol
201 burlington rd.
bedford, MA 01730
7819021665
MDR Report Key8413055
MDR Text Key138554422
Report Number3008550999-2019-00004
Device Sequence Number1
Product Code OVB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
DEN140030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSO-2101
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/11/2019
Initial Date FDA Received03/12/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age74 YR
Patient Weight82
-
-